We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $6.49B
1-Year Est. Return 10.78%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+10.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.08B
AUM Growth
+$1.15B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
165
New
Increased
Reduced
Closed

Top Buys

1 +$1.05B
2 +$23.9M
3 +$17.5M
4
AMGN icon
Amgen
AMGN
+$16.6M
5
ALGN icon
Align Technology
ALGN
+$15.4M

Sector Composition

1 Healthcare 5.8%
2 Energy 0.42%
3 Industrials 0.31%
4 Technology 0.2%
5 Real Estate 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
126
Lam Research
LRCX
$464B
$253K ﹤0.01%
+1,478
QNRX
127
Quoin Pharmaceuticals
QNRX
$6.53M
$252K ﹤0.01%
+17,448
TTWO icon
128
Take-Two Interactive
TTWO
$45.1B
$248K ﹤0.01%
+969
PM icon
129
Philip Morris
PM
$278B
$243K ﹤0.01%
1,516
+206
NTRA icon
130
Natera
NTRA
$33.6B
$238K ﹤0.01%
+1,041
ROK icon
131
Rockwell Automation
ROK
$50.8B
$229K ﹤0.01%
+588
RDDT icon
132
Reddit
RDDT
$31.9B
$226K ﹤0.01%
+982
TEAM icon
133
Atlassian
TEAM
$20.6B
$219K ﹤0.01%
+1,351
FICO icon
134
Fair Isaac
FICO
$25.5B
$203K ﹤0.01%
+120
QVCGA
135
DELISTED
QVC Group Inc Series A
QVCGA
$175K ﹤0.01%
16,696
+4,696
KLRS
136
Kalaris Therapeutics
KLRS
$106M
$169K ﹤0.01%
+20,074
AGL icon
137
Agilon Health
AGL
$1.86B
$151K ﹤0.01%
8,752
+4,193
AUR icon
138
Aurora
AUR
$12.6B
$42.1K ﹤0.01%
+10,969
IRWD icon
139
Ironwood Pharmaceuticals
IRWD
$635M
$36.9K ﹤0.01%
+10,946
FUBO icon
140
FuboTV Inc
FUBO
$256M
$31.8K ﹤0.01%
+1,050
AKRO
141
DELISTED
Akero Therapeutics
AKRO
-145,609
APLT
142
DELISTED
Applied Therapeutics
APLT
-4,487,505
ARQT icon
143
Arcutis Biotherapeutics
ARQT
$3.29B
-317,997
BRK.B icon
144
Berkshire Hathaway Class B
BRK.B
$1.06T
-2,064
CAH icon
145
Cardinal Health
CAH
$53.6B
-12,223
COR icon
146
Cencora
COR
$54.7B
-7,406
EYE icon
147
National Vision
EYE
$1.34B
-197,840
GLD icon
148
SPDR Gold Trust
GLD
$134B
0
JSPR icon
149
Jasper Therapeutics
JSPR
$13.7M
-609,053
LGND icon
150
Ligand Pharmaceuticals
LGND
$5.6B
-6,786